Researchers are exploring affective lability as a therapeutic target for bipolar disorder, but limited evidence exists on its prevalence and impact among people with schizophrenia and other psychosis spectrum disorders.
Researchers from Maastricht University in the Netherlands searched publication databases for studies of aggressive behaviors in psychiatric wards.
Researchers conducted a meta-analysis of 26 randomized clinical trials that compared fixed doses of first- and second-generation antipsychotic medications.
Pregnant women with schizophrenia experience more pregnancy, delivery, and neonatal complications versus women without severe mental disorders.
Practicing mental health counselors and counselors-in-training have better attitudes when referring to clients as “people with schizophrenia” rather than “schizophrenic.”
Investigators sought to describe suicide mortality rates and correlates among adults with schizophrenia across the lifespan.
Mental health disorders are associated with increased COVID-19-related mortality.
The researchers compared the risks and benefits of reduced vs standard doses of antipsychotics for patients with schizophrenia.
Acceptability of a passive smartphone-based ecological momentary assessment app is relatively low among individuals with schizophrenia spectrum disorders.
Individuals with psychotic disorders have a 10 to 15 year shorter life span compared with the general population, mostly due to physical conditions like obesity, cardiovascular disease, and type 2 diabetes. A cardiometabolic risk prediction algorithm can offer informed treatment decisions in order to prevent long-term cardiometabolic outcomes.
